Citation: | DU Wenyi, HU Jianping, ZUO Ke, LIU Wei, LIANG Li, DAI Tianyang. Molecular simulation study on the recognition between hydroxy isoindolin ketone derivatives and HIV-1 integrase[J]. Journal of China Pharmaceutical University, 2016, 47(5): 551-559. DOI: 10.11665/j.issn.1000-5048.20160508 |
[1] |
Gallo RC,Salahuddin SZ,Popovic M,et al.Frequent detection and isolation of cytopathic retroviruses(HTLV-III)from patients with AIDS and at risk for AIDS[J].Science,1984,224(4648):500-503.
|
[2] |
Weiss RA.How does HIV cause AIDS[J]?Science,1993,260(5112):1273-1279.
|
[3] |
David DH,Paul D,Bieniasz.HIV-1 at 25[J].Cell,2008,133(4):561-565.
|
[4] |
World Health Organization.Global summary of the AIDS epidemic[R].2013.
|
[5] |
Reddy KK, Singh SK. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors[J].Chem Biol Interact,2014,218:71-81.
|
[6] |
Hu JP,Ke GT,Chang S,et al.Studies on the binding modes of HIV-1 integrase with viral DNA via molecular docking method[J].Chem J Chin Univ(高等学校化学学报),2008,29(7):1432-1437.
|
[7] |
Zhao XZ,Maddali K,Vu BC,et al.Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones[J].Bioorg Med Chem Lett,2009,19(10):2714-2717.
|
[8] |
Wielens J,Headey SJ,Jeevarajah D,et al.Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site[J].FEBS Lett,2010,584(8):1455-1462.
|
[9] |
Schrödinger LLC.The PyMOL molecular graphics system,version 1.3r1.[EB/OL]www.pymol.org.
|
[10] |
Jorgensen WL,Chandrasekhar J,Madura JD,et al.Comparison of simple potential functions for simulating liquid water[J].J Chem Phys,1983,79(2):926-935.
|
[11] |
Ryckaert JP,Ciccotti G,Berendsen HJC.Numerical integration of the cartesian equations of dynamics of N-alkanes[J].J Comput Phys,1977,23(3):327-341.
|
[12] |
Wan H,Chang S,Hu JP,et al.Molecular dynamics simulations of ternary complexes:comparisons of LEAFY protein binding to different DNA motifs[J].J Chem Inf Model,2015,55:784-794.
|
[13] |
Feig M,Karanicolas J,Brooks C.MMTSB tool set:enhanced sampling and multiscale modeling methods for applications in structural biology[J].J Mol Graph Model,2004,22(5):377-395.
|
[14] |
Wang YJ,Rong J,Zhang B,et al.Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors[J].Bioorg Med Chem,2015,23(4):735-741.
|
[15] |
Hare S,Gupta SS,Valkov E,et al.Retroviral intasome assembly and inhibition of DNA strand transfer[J].Nature,2010,464(7286):232-236.
|
[16] |
Hu JP,Liu M,Tang DY,et al.Substrate recognition and motion mode analyses of PFV integrase in complex with viral DNA via coarse-grained models[J].PLoS One,2013,8:e54929.
|
[17] |
Hu JP,He HQ,Tang DY,et al.Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods[J]. J Biomol Struct Dyn,2013,31(7):734-747.
|
[18] |
Li Y,Xuan S,Feng Y,et al.Targeting HIV-1 integrase with strand transfer inhibitors[J].Drug Discov Today,2015,20(4):435-449.
|
[19] |
Esposito D,Craigie R.Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction[J].EMBO J,1998,17(19):5832-5843.
|
[20] |
Hu JP,Gong XQ,Su JG,et al.Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach[J].Biophys Chem,2008,132(2/3):69-80.
|
[21] |
Huang ML,Grant GH,Richards WG.Binding modes of diketo-acid inhibitors of HIV-1 integrase:a comparative molecular dynamics simulation study[J].J Mol Graph Model,2011,29(7):956-964.
|
[1] | CAI Di, TIAN Hong, YAO Wenbing. Molecular dynamics simulation and analysis of BAFF which is incorporated with p-nitro-L-phenylalanine[J]. Journal of China Pharmaceutical University, 2017, 48(2): 227-232. DOI: 10.11665/j.issn.1000-5048.20170215 |
[2] | FANG Qilu, YUE Jiping, YANG Xianyu. Cloning and its bioinformatic analysis of EDF-1 cDNA from two Bufo species[J]. Journal of China Pharmaceutical University, 2014, 45(4): 480-485. DOI: 10.11665/j.issn.1000-5048.20140417 |
[3] | TU Guogang, WANG Jiaqi, XIONG Shengtao, KUANG Binhai, LI Shaohua. Molecular dynamics simulation of matrix metalloproteinases S′1 binding pocket[J]. Journal of China Pharmaceutical University, 2013, 44(3): 219-222. DOI: 10.11665/j.issn.1000-5048.20130306 |
[4] | LI Wenhai, HOU Jinming, YOU Qidong. Synthesis and HIV-1 reverse transcriptase inhibitory activity of 3,4-disubstituted coumarin derivatives[J]. Journal of China Pharmaceutical University, 2013, 44(1): 28-34. DOI: 10.11665/j.issn.1000-5048.20130104 |
[5] | WANG Xiao-jian, ZHANG Fu-rong, CHENG Gui-fang, LI Chun, FU Ji-hua, YIN Da-li, YOU Qi-dong. Synthesis,biological evaluation and molecular docking of novel tricyclic desloratadine derivatives[J]. Journal of China Pharmaceutical University, 2012, 43(3): 193-198. |
[6] | GUO Di-liang, LIU Guan-nan, LI Jian, ZHOU Yu, XU Jin-yi, JIANG Hua-liang, LIU Hong. Improved synthesis of raltegravir[J]. Journal of China Pharmaceutical University, 2009, 40(4): 297-301. |
[7] | MIAO You-pan, LI Ai-xiu, LIU Tao, WU Ke-zhu. Molecular designing strategies of anti-drug-resistant HIV-1 protease inhibitors[J]. Journal of China Pharmaceutical University, 2009, 40(3): 279-283. |
[8] | Purificationand Assays for Activities of HIV-1 Integrase[J]. Journal of China Pharmaceutical University, 2000, (1): 72-75. |
[9] | NMR Analysis of Bromocriptine Mesilate Tenoxicam[J]. Journal of China Pharmaceutical University, 1997, (5): 33-35. |
[10] | Molecular Modeling and Conformational Analysis of Tetrahydroisoquinoline Compound CPU 23 and Nifedipine[J]. Journal of China Pharmaceutical University, 1996, (2): 70+68-70. |